Search Results - Cullingford, Erika L

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study

    Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a sin... by Iyer, Swaminathan P, Sica, R Alejandro, Ho, P Joy, Prica, Anca, Zain, Jasmine, Foss, Francine M, Hu, Boyu, Beitinjaneh, Amer, Weng, Wen-Kai, Kim, Youn H, Khodadoust, Michael S, Huen, Auris O, Williams, Leah M, Ma, Anna, Huang, Elaine, Ganpule, Avanti, Nagar, Shashwat Deepali, Sripakdeevong, Parin, Cullingford, Erika L, Karnik, Sushant, Dequeant, Mary-Lee, Patel, Janki N, He, Xinyi Shirley, Li, Ziliang, He, Qiuling Ally, Mendonez, Joy H, Keegan, Alissa, Horwitz, Steven M

    Published in The lancet oncology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Attempts at Superovulation of Mares With Porcine Follicle Stimulating Hormone and Recombinant Equine Follicle Stimulating Hormone

    Attempts at Superovulation of Mares With Porcine Follicle Stimulating Hormone and Recombinant Equine Follicle Stimulating Hormone by Cullingford, Erika L., Squires, Edward L., McCue, Patrick M., Seidel, George E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: